Loading...
Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity
The exploitation of the physiologic processing and presenting machinery of DCs by in vivo loading of tumor-associated antigens may improve the immunogenic potential and clinical efficacy of DC-based cancer vaccines. Here we show that lymphocytes genetically modified to express self/tumor antigens, a...
Na minha lista:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
American Society for Clinical Investigation
2007
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1978420/ https://ncbi.nlm.nih.gov/pubmed/17885685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI30605 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|